Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1991 Jan;154(1):63–77.

Overview of osteoporosis.

B L Riggs 1
PMCID: PMC1002677  PMID: 2024511

Abstract

Osteoporosis is a common age-related disorder manifested clinically by skeletal fractures, especially fractures of the vertebrae, hip, and distal forearm. The major cause of these fractures is low bone mass, although an increase in trauma due to falls in the elderly also contributes. There are multiple causes for the low bone mass which, in any given individual, may contribute differently to the development of the osteopenia. The most important groups of causes are failure to achieve adequate peak bone mass, slow bone loss due to processes relating to aging, the menopause in women, and a variety of sporadic behavioral, nutritional, and environmental factors that affect bone mass in some but not in other individuals. The most important approach is prevention. Drugs and behavioral factors known to cause bone loss should be eliminated and perimenopausal women should be evaluated for possible preventive administration of estrogen. For patients with fractures due to established osteoporosis, the only drugs approved by the Food and Drug Administration are the antiresorptive agents calcium, estrogen, and calcitonin. Formation-stimulating regimens, however, are being developed and may be available for clinical use in the foreseeable future. These regimens may be capable of increasing bone mass to above the fracture threshold, thereby resulting in a clinical cure of the osteoporosis.

Full text

PDF
63

Images in this article

64Image
on p.64
65Image
on p.65
65Image
on p.65
67Image
on p.67
70Image
on p.70
71Image
on p.71
71Image
on p.71
73Image
on p.73
74Image
on p.74

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aloia J. F., Vaswani A., Yeh J. K., Ellis K., Yasumura S., Cohn S. H. Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med. 1988 Mar;84(3 Pt 1):401–408. doi: 10.1016/0002-9343(88)90259-8. [DOI] [PubMed] [Google Scholar]
  2. Armbrecht H. J., Zenser T. V., Davis B. B. Effect of age on the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 by kidney of rat. J Clin Invest. 1980 Nov;66(5):1118–1123. doi: 10.1172/JCI109941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baker S. P., Harvey A. H. Fall injuries in the elderly. Clin Geriatr Med. 1985 Aug;1(3):501–512. [PubMed] [Google Scholar]
  4. Bennett A. E., Wahner H. W., Riggs B. L., Hintz R. L. Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab. 1984 Oct;59(4):701–704. doi: 10.1210/jcem-59-4-701. [DOI] [PubMed] [Google Scholar]
  5. Bergkvist L., Adami H. O., Persson I., Hoover R., Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989 Aug 3;321(5):293–297. doi: 10.1056/NEJM198908033210505. [DOI] [PubMed] [Google Scholar]
  6. Black D., Duncan A., Robins S. P. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem. 1988 Feb 15;169(1):197–203. doi: 10.1016/0003-2697(88)90274-6. [DOI] [PubMed] [Google Scholar]
  7. Bullamore J. R., Wilkinson R., Gallagher J. C., Nordin B. E., Marshall D. H. Effect of age on calcium absorption. Lancet. 1970 Sep 12;2(7672):535–537. doi: 10.1016/s0140-6736(70)91344-9. [DOI] [PubMed] [Google Scholar]
  8. Canalis E., Centrella M., Burch W., McCarthy T. L. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest. 1989 Jan;83(1):60–65. doi: 10.1172/JCI113885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Centrella M., Canalis E. Local regulators of skeletal growth: a perspective. Endocr Rev. 1985 Fall;6(4):544–551. doi: 10.1210/edrv-6-4-544. [DOI] [PubMed] [Google Scholar]
  10. Chesnut C. H., 3rd, Ivey J. L., Gruber H. E., Matthews M., Nelp W. B., Sisom K., Baylink D. J. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism. 1983 Jun;32(6):571–580. doi: 10.1016/0026-0495(83)90027-6. [DOI] [PubMed] [Google Scholar]
  11. Chetkowski R. J., Meldrum D. R., Steingold K. A., Randle D., Lu J. K., Eggena P., Hershman J. M., Alkjaersig N. K., Fletcher A. P., Judd H. L. Biologic effects of transdermal estradiol. N Engl J Med. 1986 Jun 19;314(25):1615–1620. doi: 10.1056/NEJM198606193142505. [DOI] [PubMed] [Google Scholar]
  12. Christensen M. S., Christiansen C., Naestoft J., McNair P., Transbøl I. Normalization of bone mineral content to height, weight, and lean body mass: implications for clinical use. Calcif Tissue Int. 1981;33(1):5–8. doi: 10.1007/BF02409405. [DOI] [PubMed] [Google Scholar]
  13. Civitelli R., Gonnelli S., Zacchei F., Bigazzi S., Vattimo A., Avioli L. V., Gennari C. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest. 1988 Oct;82(4):1268–1274. doi: 10.1172/JCI113725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cummings S. R., Kelsey J. L., Nevitt M. C., O'Dowd K. J. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178–208. doi: 10.1093/oxfordjournals.epirev.a036281. [DOI] [PubMed] [Google Scholar]
  15. Dalsky G. P., Stocke K. S., Ehsani A. A., Slatopolsky E., Lee W. C., Birge S. J., Jr Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med. 1988 Jun;108(6):824–828. doi: 10.7326/0003-4819-108-6-824. [DOI] [PubMed] [Google Scholar]
  16. Davidson B. J., Riggs B. L., Wahner H. W., Judd H. L. Endogenous cortisol and sex steroids in patients with osteoporotic spinal fractures. Obstet Gynecol. 1983 Mar;61(3):275–278. [PubMed] [Google Scholar]
  17. Dequeker J., Nijs J., Verstraeten A., Geusens P., Gevers G. Genetic determinants of bone mineral content at the spine and radius: a twin study. Bone. 1987;8(4):207–209. doi: 10.1016/8756-3282(87)90166-9. [DOI] [PubMed] [Google Scholar]
  18. Drinkwater B. L., Nilson K., Chesnut C. H., 3rd, Bremner W. J., Shainholtz S., Southworth M. B. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med. 1984 Aug 2;311(5):277–281. doi: 10.1056/NEJM198408023110501. [DOI] [PubMed] [Google Scholar]
  19. Duda R. J., Jr, O'Brien J. F., Katzmann J. A., Peterson J. M., Mann K. G., Riggs B. L. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. J Clin Endocrinol Metab. 1988 May;66(5):951–957. doi: 10.1210/jcem-66-5-951. [DOI] [PubMed] [Google Scholar]
  20. Eastell R., Delmas P. D., Hodgson S. F., Eriksen E. F., Mann K. G., Riggs B. L. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab. 1988 Oct;67(4):741–748. doi: 10.1210/jcem-67-4-741. [DOI] [PubMed] [Google Scholar]
  21. Eastell R., Riggs B. L. Diagnostic evaluation of osteoporosis. Endocrinol Metab Clin North Am. 1988 Sep;17(3):547–571. [PubMed] [Google Scholar]
  22. Eastell R., Riggs B. L., Wahner H. W., O'Fallon W. M., Amadio P. C., Melton L. J., 3rd Colles' fracture and bone density of the ultradistal radius. J Bone Miner Res. 1989 Aug;4(4):607–613. doi: 10.1002/jbmr.5650040419. [DOI] [PubMed] [Google Scholar]
  23. Epstein S., Bryce G., Hinman J. W., Miller O. N., Riggs B. L., Hui S. L., Johnston C. C., Jr The influence of age on bone mineral regulating hormones. Bone. 1986;7(6):421–425. doi: 10.1016/8756-3282(86)90001-3. [DOI] [PubMed] [Google Scholar]
  24. Eriksen E. F., Colvard D. S., Berg N. J., Graham M. L., Mann K. G., Spelsberg T. C., Riggs B. L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 1988 Jul 1;241(4861):84–86. doi: 10.1126/science.3388021. [DOI] [PubMed] [Google Scholar]
  25. Eriksen E. F. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev. 1986 Nov;7(4):379–408. doi: 10.1210/edrv-7-4-379. [DOI] [PubMed] [Google Scholar]
  26. Ettinger B., Genant H. K., Cann C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985 Mar;102(3):319–324. doi: 10.7326/0003-4819-102-3-319. [DOI] [PubMed] [Google Scholar]
  27. Farley J. R., Fitzsimmons R., Taylor A. K., Jorch U. M., Lau K. H. Direct effects of ethanol on bone resorption and formation in vitro. Arch Biochem Biophys. 1985 Apr;238(1):305–314. doi: 10.1016/0003-9861(85)90169-9. [DOI] [PubMed] [Google Scholar]
  28. Forero M. S., Klein R. F., Nissenson R. A., Nelson K., Heath H., 3rd, Arnaud C. D., Riggs B. L. Effect of age on circulating immunoreactive and bioactive parathyroid hormone levels in women. J Bone Miner Res. 1987 Oct;2(5):363–366. doi: 10.1002/jbmr.5650020502. [DOI] [PubMed] [Google Scholar]
  29. Foresta C., Ruzza G., Mioni R., Guarneri G., Gribaldo R., Meneghello A., Mastrogiacomo I. Osteoporosis and decline of gonadal function in the elderly male. Horm Res. 1984;19(1):18–22. doi: 10.1159/000179855. [DOI] [PubMed] [Google Scholar]
  30. Frost H. M. Treatment of osteoporoses by manipulation of coherent bone cell populations. Clin Orthop Relat Res. 1979 Sep;(143):227–244. [PubMed] [Google Scholar]
  31. Gallagher J. C., Riggs B. L., Recker R. R., Goldgar D. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med. 1989 Jul;191(3):287–292. doi: 10.3181/00379727-191-42922. [DOI] [PubMed] [Google Scholar]
  32. Genant H. K., Cann C. E., Ettinger B., Gordan G. S. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982 Nov;97(5):699–705. doi: 10.7326/0003-4819-97-5-699. [DOI] [PubMed] [Google Scholar]
  33. Genant H. K., Steiger P., Block J. E., Glueer C. C., Ettinger B., Harris S. T. Quantitative computed tomography: update 1987. Calcif Tissue Int. 1987 Oct;41(4):179–186. doi: 10.1007/BF02555236. [DOI] [PubMed] [Google Scholar]
  34. Heaney R. P., Baylink D. J., Johnston C. C., Jr, Melton L. J., 3rd, Meunier P. J., Murray T. M., Nagant de Deuxchaisnes C. Fluoride therapy for the vertebral crush fracture syndrome. A status report. Ann Intern Med. 1989 Oct 15;111(8):678–680. doi: 10.7326/0003-4819-111-8-678. [DOI] [PubMed] [Google Scholar]
  35. Heaney R. P., Gallagher J. C., Johnston C. C., Neer R., Parfitt A. M., Whedon G. D. Calcium nutrition and bone health in the elderly. Am J Clin Nutr. 1982 Nov;36(5 Suppl):986–1013. doi: 10.1093/ajcn/36.5.986. [DOI] [PubMed] [Google Scholar]
  36. Hodgson S. F., Dickson E. R., Wahner H. W., Johnson K. A., Mann K. G., Riggs B. L. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med. 1985 Dec;103(6 ):855–860. doi: 10.7326/0003-4819-103-6-855. [DOI] [PubMed] [Google Scholar]
  37. Holbrook T. L., Barrett-Connor E., Wingard D. L. Dietary calcium and risk of hip fracture: 14-year prospective population study. Lancet. 1988 Nov 5;2(8619):1046–1049. doi: 10.1016/s0140-6736(88)90065-7. [DOI] [PubMed] [Google Scholar]
  38. Judd H. L., Meldrum D. R., Deftos L. J., Henderson B. E. Estrogen replacement therapy: indications and complications. Ann Intern Med. 1983 Feb;98(2):195–205. doi: 10.7326/0003-4819-98-2-195. [DOI] [PubMed] [Google Scholar]
  39. Liel Y., Edwards J., Shary J., Spicer K. M., Gordon L., Bell N. H. The effects of race and body habitus on bone mineral density of the radius, hip, and spine in premenopausal women. J Clin Endocrinol Metab. 1988 Jun;66(6):1247–1250. doi: 10.1210/jcem-66-6-1247. [DOI] [PubMed] [Google Scholar]
  40. Lindsay R., Hart D. M., Forrest C., Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet. 1980 Nov 29;2(8205):1151–1154. doi: 10.1016/s0140-6736(80)92592-1. [DOI] [PubMed] [Google Scholar]
  41. Lindsay R., Hart D. M., MacLean A., Clark A. C., Kraszewski A., Garwood J. Bone response to termination of oestrogen treatment. Lancet. 1978 Jun 24;1(8078):1325–1327. doi: 10.1016/s0140-6736(78)92402-9. [DOI] [PubMed] [Google Scholar]
  42. Lips P., Courpron P., Meunier P. J. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res. 1978 Nov 10;26(1):13–17. doi: 10.1007/BF02013227. [DOI] [PubMed] [Google Scholar]
  43. Matković V., Kostial K., Simonović I., Buzina R., Brodarec A., Nordin B. E. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr. 1979 Mar;32(3):540–549. doi: 10.1093/ajcn/32.3.540. [DOI] [PubMed] [Google Scholar]
  44. Mazess R. B. On aging bone loss. Clin Orthop Relat Res. 1982 May;(165):239–252. [PubMed] [Google Scholar]
  45. Meier D. E., Orwoll E. S., Jones J. M. Marked disparity between trabecular and cortical bone loss with age in healthy men. Measurement by vertebral computed tomography and radial photon absorptiometry. Ann Intern Med. 1984 Nov;101(5):605–612. doi: 10.7326/0003-4819-101-5-605. [DOI] [PubMed] [Google Scholar]
  46. Melton L. J., 3rd, Cummings S. R. Heterogeneity of age-related fractures: implications for epidemiology. Bone Miner. 1987 Jul;2(4):321–331. [PubMed] [Google Scholar]
  47. Melton L. J., 3rd, Riggs B. L. Risk factors for injury after a fall. Clin Geriatr Med. 1985 Aug;1(3):525–539. [PubMed] [Google Scholar]
  48. Newton-John H. F., Morgan D. B. The loss of bone with age, osteoporosis, and fractures. Clin Orthop Relat Res. 1970;71:229–252. [PubMed] [Google Scholar]
  49. Nordin B. E., Need A. G., Morris H. A., Horowitz M. Calcitriol and osteoporosis. Ann Intern Med. 1989 Oct 15;111(8):689–689. doi: 10.7326/0003-4819-111-8-689_1. [DOI] [PubMed] [Google Scholar]
  50. Omdahl J. L., Garry P. J., Hunsaker L. A., Hunt W. C., Goodwin J. S. Nutritional status in a healthy elderly population: vitamin D. Am J Clin Nutr. 1982 Dec;36(6):1225–1233. doi: 10.1093/ajcn/36.6.1225. [DOI] [PubMed] [Google Scholar]
  51. Ott S. M., Chesnut C. H., 3rd Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med. 1989 Feb 15;110(4):267–274. doi: 10.7326/0003-4819-110-4-267. [DOI] [PubMed] [Google Scholar]
  52. Pacifici R., Rifas L., McCracken R., Vered I., McMurtry C., Avioli L. V., Peck W. A. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2398–2402. doi: 10.1073/pnas.86.7.2398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Pacifici R., Rifas L., Teitelbaum S., Slatopolsky E., McCracken R., Bergfeld M., Lee W., Avioli L. V., Peck W. A. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4616–4620. doi: 10.1073/pnas.84.13.4616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Parfitt A. M., Gallagher J. C., Heaney R. P., Johnston C. C., Neer R., Whedon G. D. Vitamin D and bone health in the elderly. Am J Clin Nutr. 1982 Nov;36(5 Suppl):1014–1031. doi: 10.1093/ajcn/36.5.1014. [DOI] [PubMed] [Google Scholar]
  55. Parfitt A. M., Mathews C. H., Villanueva A. R., Kleerekoper M., Frame B., Rao D. S. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest. 1983 Oct;72(4):1396–1409. doi: 10.1172/JCI111096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Peck W. A., Riggs B. L., Bell N. H., Wallace R. B., Johnston C. C., Jr, Gordon S. L., Shulman L. E. Research directions in osteoporosis. Am J Med. 1988 Feb;84(2):275–282. doi: 10.1016/0002-9343(88)90425-1. [DOI] [PubMed] [Google Scholar]
  57. Perry H. M., 3rd, Fallon M. D., Bergfeld M., Teitelbaum S. L., Avioli L. V. Osteoporosis in young men: a syndrome of hypercalciuria and accelerated bone turnover. Arch Intern Med. 1982 Jul;142(7):1295–1298. doi: 10.1001/archinte.142.7.1295. [DOI] [PubMed] [Google Scholar]
  58. Pocock N. A., Eisman J. A., Hopper J. L., Yeates M. G., Sambrook P. N., Eberl S. Genetic determinants of bone mass in adults. A twin study. J Clin Invest. 1987 Sep;80(3):706–710. doi: 10.1172/JCI113125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Quigley M. E., Martin P. L., Burnier A. M., Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol. 1987 Jun;156(6):1516–1523. doi: 10.1016/0002-9378(87)90025-1. [DOI] [PubMed] [Google Scholar]
  60. Reginster J. Y., Denis D., Albert A., Deroisy R., Lecart M. P., Fontaine M. A., Lambelin P., Franchimont P. 1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet. 1987 Dec 26;2(8574):1481–1483. doi: 10.1016/s0140-6736(87)92619-5. [DOI] [PubMed] [Google Scholar]
  61. Richelson L. S., Wahner H. W., Melton L. J., 3rd, Riggs B. L. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med. 1984 Nov 15;311(20):1273–1275. doi: 10.1056/NEJM198411153112002. [DOI] [PubMed] [Google Scholar]
  62. Riggs B. L., Melton L. J., 3rd Evidence for two distinct syndromes of involutional osteoporosis. Am J Med. 1983 Dec;75(6):899–901. doi: 10.1016/0002-9343(83)90860-4. [DOI] [PubMed] [Google Scholar]
  63. Riggs B. L., Melton L. J., 3rd Involutional osteoporosis. N Engl J Med. 1986 Jun 26;314(26):1676–1686. doi: 10.1056/NEJM198606263142605. [DOI] [PubMed] [Google Scholar]
  64. Riggs B. L., Wahner H. W., Dunn W. L., Mazess R. B., Offord K. P., Melton L. J., 3rd Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest. 1981 Feb;67(2):328–335. doi: 10.1172/JCI110039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Riggs B. L., Wahner H. W., Melton L. J., 3rd, Richelson L. S., Judd H. L., O'Fallon W. M. Dietary calcium intake and rates of bone loss in women. J Clin Invest. 1987 Oct;80(4):979–982. doi: 10.1172/JCI113191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Riggs B. L., Wahner H. W., Seeman E., Offord K. P., Dunn W. L., Mazess R. B., Johnson K. A., Melton L. J., 3rd Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest. 1982 Oct;70(4):716–723. doi: 10.1172/JCI110667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Rigotti N. A., Nussbaum S. R., Herzog D. B., Neer R. M. Osteoporosis in women with anorexia nervosa. N Engl J Med. 1984 Dec 20;311(25):1601–1606. doi: 10.1056/NEJM198412203112503. [DOI] [PubMed] [Google Scholar]
  68. Rodan G. A., Martin T. J. Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int. 1981;33(4):349–351. doi: 10.1007/BF02409454. [DOI] [PubMed] [Google Scholar]
  69. Rudman D., Kutner M. H., Rogers C. M., Lubin M. F., Fleming G. A., Bain R. P. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest. 1981 May;67(5):1361–1369. doi: 10.1172/JCI110164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Seeman E., Melton L. J., 3rd, O'Fallon W. M., Riggs B. L. Risk factors for spinal osteoporosis in men. Am J Med. 1983 Dec;75(6):977–983. doi: 10.1016/0002-9343(83)90878-1. [DOI] [PubMed] [Google Scholar]
  71. Slovik D. M., Rosenthal D. I., Doppelt S. H., Potts J. T., Jr, Daly M. A., Campbell J. A., Neer R. M. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res. 1986 Aug;1(4):377–381. doi: 10.1002/jbmr.5650010411. [DOI] [PubMed] [Google Scholar]
  72. Tinetti M. E., Speechley M., Ginter S. F. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988 Dec 29;319(26):1701–1707. doi: 10.1056/NEJM198812293192604. [DOI] [PubMed] [Google Scholar]
  73. Tsai K. S., Ebeling P. R., Riggs B. L. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women. J Clin Endocrinol Metab. 1989 Nov;69(5):1024–1027. doi: 10.1210/jcem-69-5-1024. [DOI] [PubMed] [Google Scholar]
  74. Tsai K. S., Heath H., 3rd, Kumar R., Riggs B. L. Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. J Clin Invest. 1984 Jun;73(6):1668–1672. doi: 10.1172/JCI111373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Wahner H. W., Dunn W. L., Brown M. L., Morin R. L., Riggs B. L. Comparison of dual-energy x-ray absorptiometry and dual photon absorptiometry for bone mineral measurements of the lumbar spine. Mayo Clin Proc. 1988 Nov;63(11):1075–1084. doi: 10.1016/s0025-6196(12)65502-5. [DOI] [PubMed] [Google Scholar]
  76. Weiss N. S., Ure C. L., Ballard J. H., Williams A. R., Daling J. R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980 Nov 20;303(21):1195–1198. doi: 10.1056/NEJM198011203032102. [DOI] [PubMed] [Google Scholar]
  77. Wilson R. J., Rao S., Ellis B., Kleerekoper M., Parfitt A. M. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med. 1988 Dec 15;109(12):959–962. doi: 10.7326/0003-4819-109-12-959. [DOI] [PubMed] [Google Scholar]
  78. Young G., Marcus R., Minkoff J. R., Kim L. Y., Segre G. V. Age-related rise in parathyroid hormone in man: the use of intact and midmolecule antisera to distinguish hormone secretion from retention. J Bone Miner Res. 1987 Oct;2(5):367–374. doi: 10.1002/jbmr.5650020503. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES